- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06035302
Madany Closure: A Novel Technique for Fascial Closure in Laparoscopic Surgery
September 17, 2023 updated by: ClinAmygate
this study aims to evaluate the effectiveness of the use of a basic laparoscopic instrument (Only needle holder) with a new technique for port site closure
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emad R Issak, MSc
- Phone Number: 01066208065
- Email: emangate@gmail.com
Study Contact Backup
- Name: Mohie El-Din M Madani, MD
- Phone Number: 01141341342
- Email: Mohie.madany@med.aswu.edu.eg
Study Locations
-
-
-
Aswan, Egypt
- Recruiting
- Aswan university hospital
-
Contact:
- Mohie El-Din M Madany, MD
- Phone Number: 01141341342
- Email: Mohie.madany@med.aswu.edu.eg
-
Principal Investigator:
- Mohie El-Din M Madany, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age . 18 years
- eligible for Laparoscopic cholecystectomy
Exclusion Criteria:
- refused to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Madany closure
the novel port site closure technique is to be done for this group
|
Madany Closure is a new technique for the porte site closure
|
Active Comparator: Control
external closure of the port site
|
Standard closure technique of the port site from ecternal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
closure time
Time Frame: 1 day
|
closure time in seconds
|
1 day
|
rate of closure failure
Time Frame: 1 day
|
rate failure to close the port site
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
incidence of port site infection
Time Frame: 1 month
|
incidence of infection of the port site
|
1 month
|
incidence of port site hernia
Time Frame: 6 weeks
|
incidence of hernia at the port site
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mohie El-Din M Madani, MD, Aswan university hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2023
Primary Completion (Estimated)
November 15, 2023
Study Completion (Estimated)
December 15, 2023
Study Registration Dates
First Submitted
September 6, 2023
First Submitted That Met QC Criteria
September 6, 2023
First Posted (Actual)
September 13, 2023
Study Record Updates
Last Update Posted (Actual)
September 21, 2023
Last Update Submitted That Met QC Criteria
September 17, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR00C1940
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystolithiasis
-
University of Roma La SapienzaCompleted
-
Hadassah Medical OrganizationCompleted
-
University of Roma La SapienzaCompleted
-
St John of God Hospital, ViennaCompleted
-
University of ZurichCompletedCholecystolithiasisSwitzerland
-
Hvidovre University HospitalUnknown
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
National Yang Ming Chiao Tung University HospitalCompleted
-
American University of Beirut Medical CenterMakassed General HospitalUnknown
-
Colchester Hospital University NHS Foundation TrustEthicon, Inc.Withdrawn
Clinical Trials on Madany Closure
-
Aswan University HospitalCompletedLaparoscopic Cholecystectomy | Cholecystitis; GallstoneEgypt
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Cancer Institute... and other collaboratorsUnknownRectal Cancer | Anal Canal Cancer
-
Turku University HospitalCompletedSurgical Wound InfectionFinland
-
Mayo ClinicCompletedTotal Knee ArthroplastyUnited States
-
Wake Forest University Health SciencesTerminated
-
NYU Langone HealthCompleted
-
Wake Forest University Health SciencesOrthopaedic Trauma Association; Orthopaedic Research and Education FundCompletedType II and IIa Open Tibia FracturesUnited States
-
University of MinnesotaCentre Hospitalier Universitaire VaudoisCompleted
-
Ataturk UniversityCompletedCesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
University of California, San DiegoZipLine Medical Inc.Completed